Pinghan Wang

Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment

Lei Xu, Xiang Zhang, X. Zou, 2022, Theranostics.

Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance

Yuxi Wang, Fangyi Long, Hong Lin, 2022, Molecular Cancer.

Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer

Fangyi Long, Hong Lin, Ting Wang, 2022, Oxidative medicine and cellular longevity.

Dietary phytochemicals targeting Nrf2 for chemoprevention in breast cancer.

Fangyi Long, Hong Lin, Ting Wang, 2022, Food & function.

Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation

Fangyi Long, Hong Lin, Ting Wang, 2022, Frontiers in Molecular Biosciences.

Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective

Fangyi Long, Ting Wang, Pinghan Wang, 2024, Cellular & molecular biology letters.

The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications

Fangyi Long, Ting Wang, Pinghan Wang, 2024, Cell death & disease.

Chemopreventive effects of atractylenolide-III on mammary tumorigenesis via activation of the Nrf2/ARE pathway through autophagic degradation of Keap1.

Fangyi Long, Ting Wang, Pinghan Wang, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.